Last update:

Allergy and immunology news

Designing global flu vaccines? Studies suggest common IGHD deletions may block key antibodies

Inherited variations in antibody genes can affect how we respond to infections and vaccines, show two new studies from Karolinska Institutet published in the journal Immunity. The researchers have mapped immune gene variation ...

Single-cell study reveals how immune memory cells remember threats

Scientists at Cincinnati Children's have identified how certain immune cells are molecularly programmed to respond faster when the body encounters a familiar threat, shedding light on immune memory and its links to diseases ...

Living with dogs: Examining asthma outcomes in children

Living with a dog does not seem to worsen long-term asthma severity in children with allergic asthma, but may increase the risk of asthma exacerbations slightly, according to a study from Karolinska Institutet in Sweden that ...

Existing medication can restore HIV-affected immune cells

HIV exhausts the body's immune system by overactivating it, despite effective antiviral treatment. Researchers from Linköping University in Sweden have conducted cell studies showing that an existing medication restores immune ...

Dual immune response may keep HIV in check without medication

Imagine a game of chess where your opponent's king is in check. It cannot move, but the game is not over—the piece remains on the board. This is how the body might control HIV on its own: The virus would be contained and ...

Skin's immune response could be key to fighting dengue

Dengue, a mosquito-borne viral disease, infects an estimated 390 million people and causes around 20,000 deaths worldwide each year. New research suggests the skin is a major site of immune surveillance for dengue. The findings ...

A genetic blueprint for avoiding killer T cell exhaustion

A multi-institutional study led by researchers at UNC Lineberger Comprehensive Cancer Center, the Salk Institute for Biological Studies, and UC San Diego has uncovered new genetic rules that determine how powerful immune ...

A more reliable platform to test antibody medicines

An international research consortium, led by scientists at VIB and UGent, has developed a new platform that could change how antibody medicines are tested and brought to patients. The work, published in Science Immunology, ...

How does long COVID develop? New piece of the puzzle found

How long COVID develops is still largely unknown. New molecular connections are revealed in a recent study led by the Center for Individualized Infection Medicine (CiiM), which is a joint institution of the Helmholtz Center ...

Team unveils simpler, faster way to make vaccines

UVA Health scientists have developed a promising new way to create vaccines that could be faster, cheaper, and easier to distribute than current options. The University of Virginia School of Medicine's Dr. Steven L. Zeichner ...